TWST

Twist Bioscience Corporation

$68.00

+$3.83 (5.97%)
Time to buy TWST?
Prices delayed. Get real-time quotes here!
2 Days. Real Options Skills.

2 Days. Real Options Skills.

Join options trader Ben Sturgill as he reveals his most reliable options strategies - live. Seats are limited.

Save your seat

Trader's Perspective

TWST ran from roughly $56 after its May 4 earnings report to $69.13 on May 28 as traders leaned into record revenue, raised fiscal 2026 guidance, and a fresh analyst upgrade.

RANGE
Support: $64Current: $67.90 Target: $70
BEARISH SCENARIO

The stock has the potential to go down if it loses $64, with room to fade toward $60 to $61. Any sign that growth is slowing, or that the path to fourth quarter adjusted EBITDA breakeven is slipping, would likely speed up the downside.

BULLISH SCENARIO

If TWST holds the $64 to $66 area on volume, a push back into $69 to $70 is on the table. Resistance at $69.10 is the first hurdle, and a clean break could open a test of the round $72 area.

CATALYSTS:
Analysis generated: May 28, 2026 at 1:48 PM ET

Top Gainers

Analyst Ratings

N/A
Average Price Target: $0
Based on 0 analyst ratings in the last 3 months
Sell
0
Hold
0
Buy
0

Twist Bioscience Corporation Earnings

We don't currently have information about Twist Bioscience Corporation's earnings.

The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders